AstraZeneca is responding to the COVID-19 (novel coronavirus) outbreak, consistent with our values to follow the science, put patients first and do the right thing.
The COVID-19 pandemic is placing immediate challenges on our healthcare systems and will also have a longer lasting impact on the way we live and think about our health. As a company, our priority is to respond to the needs of patients and help ensure their safety and continued access to care and medicines, as well as to play our part in helping to relieve the pressure on healthcare systems during this critical period.
To do this we are partnering with governments, international organizations, health professionals, industry and the patient community to provide emergency relief support, as well as helping to rapidly scale up solutions to unclog healthcare systems, allowing patients with chronic diseases to continue to be treated. We are also contributing to the process of scientific innovation that can combat the virus.Our response is based on four core objectives: